PMC:7291971 / 22531-22612
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T502 | 39-48 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T503 | 57-65 | SP_10 | denotes | SARS-CoV |
T504 | 66-71 | PR:000000125 | denotes | nsp14 |
T505 | 76-81 | PR:O43148 | denotes | hRNMT |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T58 | 57-65 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T183 | 19-26 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T157 | 0-81 | Sentence | denotes | 2.4 Dose-response testing of selected compounds against SARS-CoV nsp14 and hRNMT |